INOZYME PHARMA INC. -
5,2100
07-октября-24 15:59:31
15 мин. задержка
Акции
+0,0400
+0,77%
Сегодняшний диапазон
5,1200 - 5,2800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 май 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
14 апр 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
11 апр 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
04 апр 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
22 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
01 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
16 фев 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023
06 фев 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress
09 янв 2023 08:30:00 Источник Nasdaq GlobeNewswire
-
05 дек 2022 08:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the BofA Securities Biotech SMID Cap Conference
01 дек 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
10 ноя 2022 08:30:01 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in Upcoming Investor Conferences
07 ноя 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
03 ноя 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Publication of Comprehensive ENPP1 Variant Database
31 окт 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 сен 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
15 авг 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
26 июл 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
19 июл 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
16 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire